Bruton's Tyrosine Kinase inhibition by Acalabrutinib does not affect early or advanced atherosclerotic plaque size and morphology in Ldlr mice-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Bruton's Tyrosine Kinase inhibition by Acalabrutinib does not affect early or advanced atherosclerotic plaque size and morphology in Ldlr mice

Published:2023-06 Issue: Volume:150 Page:107172
ISSN:1537-1891
Container-title:Vascular Pharmacology
language:en
Short-container-title:Vascular Pharmacology

Author:

Hemme Esmeralda,Biskop Danique,Depuydt Marie A.C.,Smit Virginia,Delfos Lucie,Bernabé Kleijn Mireia N.A.,Foks Amanda C.,Kuiper Johan,Bot Ilze

Funder

Hartstichting

Publisher

Elsevier BV

Subject

Pharmacology,Molecular Medicine,Physiology

Reference34 articles.

1. Impact of statin therapy on coronary plaque composition: a systematic review and meta-analysis of virtual histology intravascular ultrasound studies;Banach;BMC Med.,2015

2. Mast cells as effectors in atherosclerosis;Bot;Arterioscler. Thromb. Vasc. Biol.,2015

3. The human mast cell: an overview;Krishnaswamy;Methods Mol. Biol.,2006

4. Mast cells promote atherosclerosis by inducing both an atherogenic lipid profile and vascular inflammation;Heikkilä;J. Cell. Biochem.,2010

5. Perivascular mast cells promote atherogenesis and induce plaque destabilization in apolipoprotein E-deficient mice;Bot;Circulation,2007

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic strategies in FcγIIA receptor-dependent thrombosis and thromboinflammation as seen in heparin-induced thrombocytopenia (HIT) and vaccine-induced immune thrombocytopenia and thrombosis (VITT);Expert Opinion on Pharmacotherapy;2024-02-11

2. Cellular and Molecular Mechanisms of Mast Cells in Atherosclerotic Plaque Progression and Destabilization;Clinical Reviews in Allergy & Immunology;2024-01-30

3. Identification and validation of hub genes involved in foam cell formation and atherosclerosis development via bioinformatics;PeerJ;2023-10-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3